Leukemia hiding in a routine CBC. Sickle cell crises predicted before they strike. Infections typed before cultures return. Sentinel Hema reads blood the way it was meant to be read — every cell, every parameter, every pattern.
The complete blood count is the most ordered laboratory test in the world — and the most underread. Clinicians glance at hemoglobin, white count, and platelets. If they're "normal," the report is filed. But buried within those 37+ parameters are patterns that reveal leukemia months before blasts appear, infections hours before cultures turn positive, iron deficiency before anemia develops, and bone marrow stress before the patient decompensates. The CBC is not a screening test. It is a diagnostic oracle — if you have the intelligence to read it.
Sentinel Hema transforms hematological analysis from a counting exercise into an AI-powered diagnostic intelligence platform. It analyzes every CBC parameter, every cell on the peripheral smear, every trend across serial draws — and correlates them with clinical context, medication profiles, and disease trajectories to surface the diagnoses that routine interpretation misses.
These conditions are detectable in routine blood work — but only if someone (or something) is looking for the pattern.
From automated differential to peripheral smear morphology to longitudinal trend analysis — Sentinel Hema reads blood the way the world's best hematologist would if they had unlimited time and perfect memory.
Clinicians read CBCs parameter by parameter — hemoglobin, WBC, platelets — comparing each to a reference range. But disease hides in the relationships between parameters, not in any single value. A WBC of 9.2 is "normal." A platelet count of 155 is "normal." A hemoglobin of 11.8 is "borderline." But the combination — with an elevated RDW, low reticulocyte production index, and falling MCV trend — is the signature of myelodysplastic syndrome months before blasts appear. Sentinel Hema evaluates all 37+ parameters as a constellation, not a checklist, and cross-references the pattern against a library of 200+ hematological disease signatures.
A standard blood smear contains thousands of individual cells — far more than any human microscopist can examine. Studies show 15-20% discordance rates between experienced microscopists examining identical smears. Sentinel Hema's AI morphology engine scans every cell on the smear at oil-immersion resolution, classifying each into 30+ cell types, flagging morphological abnormalities (blasts, atypical lymphocytes, dysplastic forms, schistocytes, sickle cells, parasites), and generating a quantified morphology report that triages routine cases and highlights anything unusual for human review.
Blood cancers often announce themselves in routine blood work months before clinical diagnosis — through subtle cytopenias, gradual lymphocytosis, circulating immature cells, or morphological dysplasia visible only on careful smear review. Yet these early signals are frequently missed because automated analyzers lack the morphological discrimination and clinical context to flag them. Sentinel Hema's malignancy detection engine monitors CBC trends longitudinally, analyzes smear morphology for blast cells and dysplastic forms, correlates findings with patient demographics and clinical context, and generates a hematologic malignancy risk score that triggers appropriate workup — flow cytometry, bone marrow biopsy, or hematology referral — before the disease declares itself clinically.
Anemia affects 1.6 billion people worldwide, but "anemia" is not a diagnosis — it is a symptom with dozens of etiologies, each requiring different treatment. Iron deficiency. B12 deficiency. Folate deficiency. Chronic disease. Hemolysis. Thalassemia. Sideroblastic anemia. Aplastic anemia. Each leaves a distinctive fingerprint in the CBC — MCV, MCH, MCHC, RDW, reticulocyte count, reticulocyte hemoglobin content (CHr), and immature reticulocyte fraction (IRF) — that Sentinel Hema reads as a pattern to classify etiology with 91% accuracy from the CBC alone, often eliminating the need for expensive and time-consuming iron studies, B12/folate levels, and hemoglobin electrophoresis as first-line tests.
The coagulation system is invisible on a standard CBC — until it fails catastrophically. But the early signals are present: falling platelet trends, rising mean platelet volume (immature platelets entering circulation), elevated immature platelet fraction, widening PT/INR, and rising D-dimer. Sentinel Hema correlates these with peripheral smear findings (schistocytes for microangiopathic hemolysis, platelet clumping artifacts) and clinical context to detect DIC, thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), heparin-induced thrombocytopenia (HIT), and immune thrombocytopenia (ITP) — conditions where delayed diagnosis is measured in lives, not days.
Infections leave distinctive fingerprints in the blood that are visible long before culture results return. Bacterial infections produce left shift (elevated bands, metamyelocytes, immature granulocytes), toxic granulation, and Döhle bodies. Viral infections produce atypical lymphocytes and relative lymphocytosis. Parasitic infections elevate eosinophils. Fungal infections in immunocompromised patients produce subtle monocyte and neutrophil changes. Sentinel Hema reads these morphological and quantitative patterns to type the infection and assess severity — enabling targeted empiric therapy 24-48 hours before culture results confirm the pathogen.
The bone marrow communicates its status through the blood. Pancytopenia patterns, leukoerythroblastic pictures (nucleated red blood cells and immature white cells in circulation), teardrop cells suggesting myelofibrosis, circulating plasma cells suggesting myeloma, and reticulocyte patterns revealing production failure — all visible on CBC and peripheral smear, all interpretable by AI, and all requiring different and often urgent clinical responses. Sentinel Hema monitors these marrow stress indicators to identify patients who need bone marrow biopsy, hematology referral, or urgent evaluation for marrow infiltration by metastatic cancer.
A single CBC is a snapshot. A series of CBCs over months and years is a movie — and in that movie, the trajectory of disease becomes visible long before any single value crosses a threshold. A hemoglobin that has drifted from 14.2 to 12.8 over two years is "normal" on every individual draw but represents a trajectory that demands investigation. A platelet count falling from 240 to 160 over six months — always "normal" — is the signature of an occult myeloproliferative disorder or early ITP. Sentinel Hema analyzes every historical CBC, calculates trajectories for all 37+ parameters, identifies statistically significant trends, and alerts clinicians to the slow-motion deterioration that point-in-time interpretation will always miss.
Results from our deployed health systems.
Sentinel Hema's peripheral smear AI and longitudinal trend engine were deployed across all CBC orders in a 900-bed academic medical center. In the first year, the system flagged 23 cases of suspected hematologic malignancy from routine blood work — 19 of which were confirmed on subsequent flow cytometry and bone marrow biopsy. Of these 19 confirmed cases, 14 were identified at a stage earlier than would have been detected through standard clinical pathways. The hematology department estimated that earlier detection advanced treatment initiation by an average of 3.4 months across these patients.
Deployed across 6 community hospitals, Sentinel Hema's infection typing engine analyzed CBC morphology patterns for every patient with a suspected infection. By differentiating bacterial from viral patterns 24-48 hours before culture results, the system enabled clinicians to narrow antibiotic therapy earlier in 1,840 cases. Unnecessary broad-spectrum antibiotic days dropped 38%. For emergency departments, the system's rapid infection severity assessment reduced time to appropriate therapy by 3.1 hours in bacterial cases — a metric with direct mortality implications.
Deployed across a 48-clinic primary care network serving 380,000 patients, the longitudinal trend engine analyzed historical CBC data to identify patients with slowly developing hematological abnormalities. In the first year, it flagged 2,400 patients with trending parameters warranting evaluation — of whom 860 had actionable findings (iron deficiency pre-anemia, B12 deficiency, early MDS, monoclonal B-cell lymphocytosis). Eight patients were found to have early-stage MDS that would not have been detected for months to years under standard care. Primary care physicians reported that the system transformed their approach to "normal" CBC results.
I've been a hematopathologist for twenty-six years. I've looked at more blood smears than I can count. And I will tell you plainly: this AI sees things I miss. Not because I'm not good at what I do — but because a human cannot examine 500,000 cells on a smear and maintain the same attention on cell 499,000 as on cell one. The machine can. And it does.
The longitudinal trend engine changed how I practice primary care medicine. I used to file a CBC with "normal" hemoglobin and move on. Now I see that my patient's hemoglobin has dropped from 14.1 to 12.4 over three years — still "normal" every time, but the trajectory screams iron depletion. I caught a colon cancer from a CBC trend. A colon cancer. From a routine blood test. That is what this system does.
For my sickle cell patients, the crisis prediction capability is life-changing — literally. We can see the reticulocyte count climbing, the LDH rising, the haptoglobin falling — and we intervene with hydration and pain management before the crisis hits. My patients are spending fewer nights in the emergency department. That's not a metric. That's a life.
Schedule a clinical demonstration of Sentinel Hema — configured for your laboratory volume, your analyzer integration, and your patient population.